Trial Profile
Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Embolism; Stroke
- Focus Therapeutic Use
- 03 Nov 2015 New trial record